We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLO icon
2076
Allogene Therapeutics
ALLO
$694M
$162K ﹤0.01%
6,230
+1,065
+21% +$30.4K
CWT icon
2077
California Water Service
CWT
$3.12B
$162K ﹤0.01%
2,908
-2,865
-50% -$165K
NGVC icon
2078
Vitamin Cottage Natural Grocers
NGVC
$654M
$162K ﹤0.01%
15,102
+14,854
+5,990% +$201K
PSNL icon
2079
Personalis
PSNL
$1.51B
$162K ﹤0.01%
6,376
-607
-9% -$13.9K
SLE icon
2080
Super League Enterprise
SLE
$4.65M
$162K ﹤0.01%
3
-3
-50% -$154K
SGFY
2081
DELISTED
Signify Health, Inc.
SGFY
$162K ﹤0.01%
5,337
-18
-0.3% -$495
APPN icon
2082
Appian
APPN
$2.48B
$161K ﹤0.01%
1,167
-2,281
-66% -$259K
ANF icon
2083
Abercrombie & Fitch
ANF
$5B
$160K ﹤0.01%
3,436
-10,440
-75% -$421K
JNPR
2084
DELISTED
Juniper Networks
JNPR
$160K ﹤0.01%
5,854
-40,591
-87% -$1.08M
P
2085
Everpure Inc
P
$29.9B
$160K ﹤0.01%
8,192
-94,417
-92% -$1.86M
RNAM
2086
DELISTED
Avidity Biosciences
RNAM
$160K ﹤0.01%
6,474
+5,056
+357% +$118K
RRR icon
2087
Red Rock Resorts
RRR
$3.62B
$160K ﹤0.01%
3,768
-2,323
-38% -$91.8K
CERS icon
2088
Cerus
CERS
$474M
$159K ﹤0.01%
26,828
-57,793
-68% -$339K
KYNB
2089
Kyntra Bio
KYNB
$29.4M
$159K ﹤0.01%
238
-174
-42% -$100K
FCBP
2090
DELISTED
First Choice Bancorp Common Stock
FCBP
$159K ﹤0.01%
5,225
+4,033
+338% +$120K
AIV
2091
Aimco
AIV
$383M
$158K ﹤0.01%
23,440
+6,130
+35% +$42.2K
AUB icon
2092
Atlantic Union Bankshares
AUB
$5.97B
$158K ﹤0.01%
4,373
-2,164
-33% -$84.9K
KALV
2093
DELISTED
KalVista Pharmaceuticals
KALV
$158K ﹤0.01%
6,601
+2,917
+79% +$76.3K
LAZ icon
2094
Lazard
LAZ
$4.31B
$158K ﹤0.01%
3,494
-4,846
-58% -$222K
THFF icon
2095
First Financial Corp
THFF
$969M
$158K ﹤0.01%
3,881
+2,366
+156% +$105K
ARGO
2096
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$158K ﹤0.01%
3,050
+267
+10% +$14.4K
TPTX
2097
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$158K ﹤0.01%
2,032
-1,336
-40% -$98.7K
APTS
2098
DELISTED
Preferred Apartment Communities, Inc.
APTS
$158K ﹤0.01%
16,198
+11,538
+248% +$117K
EWU icon
2099
iShares MSCI United Kingdom ETF
EWU
$4.16B
$157K ﹤0.01%
+4,802
New +$159K
CG icon
2100
Carlyle Group
CG
$17.2B
$156K ﹤0.01%
3,361
-4,815
-59% -$205K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.